好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2016 Annual Meeting | Neuromuscular Junction Disorders I

Thursday 04/21/16
01:00 PM - 03:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Laura M. Tormoehlen, MD, FAAN
Participants should be familiar with the diagnosis and management of patients with myasthenia gravis and related disorders; learn to critically select therapies; and be able to distinguish myasthenia gravis, MuSK myasthenia, Lambert-Eaton syndrome, and recognize the less common disorders of neuromuscular transmission.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Trainee, General Neurologist, Specialist Neurologist
Case-based, Didactic
Event Timeline
01:00 PM - 01:05 PM Introduction
01:05 PM - 01:55 PM Presentation and Diagnosis of Myasthenia Gravis
Janice M. Massey, MD, FAAN
01:55 PM - 02:45 PM Treating Myasthenia Gravis in 2016
Jeff Guptill, MD, FAAN
02:45 PM - 03:00 PM Discussion
Faculty Disclosures
Laura M. Tormoehlen, MD, FAAN The institution of Dr. Tormoehlen has received research support from Genentech. Dr. Tormoehlen has received publishing royalties from a publication relating to health care.
Jeff Guptill, MD, FAAN Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has stock in argenx.
Janice M. Massey, MD, FAAN Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenix. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance Therapeutics. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta. The institution of Dr. Massey has received research support from Revance .